Compugen Stock

Compugen SG&A Expenses

The Selling, General & Administrative Expenses of Compugen (CGEN) as of Aug 9, 2026 is 8.89 M USD. In the previous year, Selling, General & Administrative Expenses was 9.44 M USD — a change of -5.81% (lower).

SG&A Expenses

8.89 MUSD

YoY

-5.81%

Last updated:

Selling, General & Administrative Expenses of Compugen is 2026 8.89 M USD. Selling, General & Administrative Expenses of Compugen was 2025 9.44 M USD. It decreases by -5.81% lower compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Selling, General & Administrative Expenses of Compugen is 8.89 M USD in 2026.

Selling, General & Administrative Expenses of Compugen changed from 9.44 M USD to 8.89 M USD, representing a -5.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Selling, General & Administrative Expenses Compugen since 2006 – with annual values, charts, and detailed analysis.

SG&A expenses include all non-production costs such as salaries, marketing, rent, and administrative overhead. They are a key component of operating expenses.

Selling, General & Administrative Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Selling, General & Administrative Expenses's Compugen historically and in real time.

Access this data via the Eulerpool API

Income Statement — Compugen

All Key Metrics — Compugen